GCTK
GlucoTrackCNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-02
Current thesis
If management uses the hearing to keep Nasdaq listing intact and can show a believable path to restore bid-price and equity compliance, the stock retains option value on the glucose-monitor program; even incremental de-risking can matter at this size.
Posture
Mixed
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite.
What can break
Extreme micro-cap liquidity and volatility; small headlines can dominate price action.
Momentum
92
Value
58
Sentiment
15
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $0.34 · Bull $0.88 · Bear $0.10
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-19 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Why
Momentum92 · Δ7d -
Value58 · Δ7d +0.1
Sentiment15 · Δ7d -
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Momentum · See technicals
Momentum
92
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
58
32% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.5
Sentiment
15
33% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade C. Momentum 91.9 / Value 57.6 / Sentiment 15.4
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$4.11M
Beta
0.33
Shares Out
910.69K
P/E (TTM) · Derived
-0.0
P/S (TTM)
-
P/FCF (TTM) · Derived
-0.12
Rev YoY
-
EPS YoY
+99.6%
Gross Margin
-
Op Margin
-
Net Debt
-$5.41M
Current Ratio
1.53
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology